Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ZyCoV-D Emergency use authorization Experimental Vaccine Mar/26/2020 1 0
Zotatifin Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
Zotarolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/23/2020 1 0
Zofin Potential treatment - clinical evidence Experimental Other treatment Mar/17/2021 1 0
ZINC96222891 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC95559591 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
ZINC4511851 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
ZINC4326719 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
ZINC29416466 Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020 1 0
ZINC218242102 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC1775962367 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
ZINC16429284 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC1570001158 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC15275997 Potential treatment - theoretical effect Experimental Antiviral Jul/31/2020 1 0
ZINC104875569 Potential treatment - theoretical effect Experimental Antiviral Feb/08/2021 1 0
ZINC000026985532 Potential treatment - theoretical effect Experimental Antiviral Aug/03/2020 1 0
Zinc sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/16/2021 3 0
Zilpaterol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/23/2020 1 0
ZF2001 Potential treatment - clinical evidence Experimental Vaccine Mar/24/2021 1 0
Zanamivir Potential treatment - theoretical effect Used to treat other disease Antiviral Oct/20/2020 1 0
Z93 Potential treatment - theoretical effect Experimental Antiviral Sep/13/2020 1 0
Z LVG CHN2 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
Z-FA-FMK Potential treatment - pre-clinical evidence Experimental Antiviral Jan/24/2021 2 0
YM201636 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020 1 0
YM-161514 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 1 0
YKYRYL peptide Potential treatment - theoretical effect Experimental Antiviral Aug/27/2020 1 0
Yindan Jiedu Potential treatment - clinical evidence Natural product Antiviral Feb/05/2021 1 0
YH-1238 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
YF-S0 Potential treatment - pre-clinical evidence Experimental Vaccine Dec/01/2020 1 0
Y-320 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021 1 0
Xue Bi Jing Potential treatment - clinical evidence Natural product Other treatment Sep/10/2020 2 0
Xuanfei Baidu decoction Potential treatment - clinical evidence Experimental Unknown Jul/25/2020 1 0
XL413 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
XG014 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/12/2021 1 0
X-206 Potential treatment - pre-clinical evidence Experimental Antiviral Nov/25/2020 1 0
WYE-125132 Potential treatment - pre-clinical evidence Experimental Antiviral Mar/23/2021 1 0
Wogonin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 2 0
WNbFc 7 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 36 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 2 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WNbFc 15 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021 1 0
WIV04 strain vaccine Potential treatment - clinical evidence Experimental Vaccine Aug/13/2020 1 0
Withanoside V Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
Withanone Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021 2 0
Withanolide R Potential treatment - theoretical effect Natural product Antiviral Mar/18/2021 1 0
Withanolide A Potential treatment - theoretical effect Natural product Antiviral Nov/05/2020 1 0
Withaferin A Potential treatment - theoretical effect Natural product Antiviral Jun/16/2020 1 0
WiNeWsE Potential treatment - pre-clinical evidence Natural product Antiviral Mar/11/2021 1 0
WDB002 Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
W4P-RBD Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021 1 0
W25 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/08/2021 1 0
VSV-eGFP-SARS-CoV-2 Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020 1 0
VS12 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021 1 0
VS10 Potential treatment - pre-clinical evidence Experimental Antiviral Feb/24/2021 1 0
VS-5584 Potential treatment - theoretical effect Experimental Antiviral Nov/05/2020 1 0
VR17-04 Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/21/2020 1 0
VPS34-INI Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020 1 0
Vortioxetine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/05/2021 2 0
Vorinostat Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/12/2021 1 0
Vitexfolin A Potential treatment - theoretical effect Natural product Antiviral Aug/22/2020 1 0
Vitamin D3 Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/17/2021 2 1
Vitamin B12 Potential treatment - clinical evidence Natural product Other treatment Aug/18/2020 2 0
Vistusertib Potential treatment - pre-clinical evidence Experimental Antiviral Mar/25/2021 2 0
Viomycin Potential treatment - theoretical effect Used to treat other disease Antiviral Sep/10/2020 1 0
Vinorelbine Potential treatment - theoretical effect Used to treat other disease Other treatment Jun/27/2020 1 0
Vincapusine Potential treatment - theoretical effect Natural product Antiviral Jul/17/2020 1 0
Vidarabine Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/21/2020 1 0
Vicenin Potential treatment - theoretical effect Natural product Antiviral Aug/27/2020 1 0
VHH WE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH W Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH VE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH V Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH U Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH-Fcs 3F-1B-2A Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VHH-Fcs 1B-3F-2A Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VHH EW Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH EV Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH EEE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH EE Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH E Potential treatment - pre-clinical evidence Experimental Antiviral Feb/12/2021 1 0
VHH-72-VHH-72 Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020 1 0
VHH-72-Fc Potential treatment - pre-clinical evidence Experimental Antiviral May/05/2020 1 0
VH3 B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VH2 A01-B02 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VH2 A01-B01 Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
VH-Fc ab8 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/29/2021 2 0
Verteporfin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/09/2020 2 0
Verdinexor Potential treatment - theoretical effect Experimental Antiviral Apr/30/2020 1 0
Velutin Potential treatment - theoretical effect Natural product Antiviral Jan/04/2021 1 0
Velpatasvir Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/26/2021 1 0
VBY-825 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
Valrubicin Potential treatment - theoretical effect Experimental Antiviral Feb/02/2021 1 0
Valproic Acid Potential treatment - theoretical effect Used to treat other disease Antiviral Apr/30/2020 1 0
Valaciclovir Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/05/2020 1 0
Vacuolin-1 Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 1 0
Ursonic acid Potential treatment - theoretical effect Natural product Antiviral Sep/03/2020 1 0
Ursolic acid Potential treatment - theoretical effect Natural product Antiviral Nov/04/2020 2 0
Uridine triphosphate Potential treatment - theoretical effect Natural product Antiviral Aug/05/2020 1 0
Uncaria tomentosa extract Potential treatment - pre-clinical evidence Natural product Antiviral Feb/24/2021 1 0
UCN-01 Potential treatment - theoretical effect Experimental Other treatment May/17/2020 1 0